Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.
[Association between Multiple Sclerosis or Neuromyelitis Optica and Epstein-Barr Virus].
Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.
Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients.
The astrocyte in multiple sclerosis revisited.
Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study.
A review of induced pluripotent stem cell, direct conversion by trans-differentiation, direct reprogramming and oligodendrocyte differentiation.
Phosphodiesterase-5 inhibition promotes remyelination by MCP-1/CCR-2 and MMP-9 regulation in a cuprizone-induced demyelination model.
Sphingosine kinase inhibition ameliorates chronic hypoperfusion-induced white matter lesions.
A retrospective case series of pediatric spinal cord injury and disease in Victoria, Australia.
Effect of Bushen Yisui Capsule () on oligodendrocyte lineage genes 1 and 2 in mice with experimental autoimmune encephalomyelitis.
[Thoughts on hot issues of neuromyelitis optica].
Design, Synthesis, and Evaluation of Fluorinated Radioligands for Myelin Imaging.
Dystonic pattern in a fibromyalgia patient: Relevance of a biopsychosocial rehabilitation approach.
A systems pharmacology approach to decipher the mechanism of danggui-shaoyao-san decoction for the treatment of neurodegenerative diseases.
Reliability and responsiveness of cardiopulmonary exercise testing in fatigued persons with multiple sclerosis and low to mild disability.
Novel therapeutic options for multiple sclerosis.
More on JC viremia in natalizumab-treated patients with multiple sclerosis.
Serum complement factor and Tyr4O2 His gene polymorphism among Egyptians with multiple sclerosis.
Interferon-Beta Therapy of Multiple Sclerosis Patients Improves the Responsiveness of T Cells for Immune Suppression by Regulatory T Cells.
A proposed dosing algorithm for the individualized dosing of human immunoglobulin in chronic inflammatory neuropathies.
Progressive Multifocal Leukoencephalopathy.
Evidence for Borna disease virus infection in neuropsychiatric patients in three western China provinces.
Exogenous Adult Post Mortem Neural Precursors attenuate secondary degeneration, and promote myelin sparing and functional recovery following experimental spinal cord injury.
Widespread synaptic loss in multiple sclerosis.
Pages
« first
‹ previous
…
616
617
618
619
620
621
622
623
624
…
next ›
last »